(Q53931563)

22 May 2018

title

Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma. (English)

1 reference

22 May 2018

main subject

asthma

0 references

author name string

M P Rutten-van Mölken

series ordinal

1

1 reference

22 May 2018

E K van Doorslaer

series ordinal

2

1 reference

22 May 2018

M D Till

series ordinal

3

1 reference

22 May 2018

publication date

1 December 1998

1 reference

22 May 2018

published in

PharmacoEconomics

1 reference

22 May 2018

volume

14

1 reference

22 May 2018

issue

6

1 reference

22 May 2018

page(s)

671-684

1 reference

22 May 2018

https://scigraph.springernature.com/pub.10.2165/00019053-199814060-00007

exact match

0 references

cites work

Long-term efficacy of formoterol compared to salbutamol

1 reference

https://api.crossref.org/works/10.2165%2F00019053-199814060-00007

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-199814060-00007

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-199814060-00007

Validation of an asthma quality of life diary in a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-199814060-00007

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-199814060-00007

The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-199814060-00007

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-199814060-00007

Conversion factor instability in international comparisons of health care expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-199814060-00007

Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma

21 January 2018

1 reference

12 December 2020

Assessing the cost effectiveness of NSAID: an international perspective.

1 reference

12 December 2020

Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life

1 reference

12 December 2020

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

12 December 2020

Should clinical trials with concurrent economic analyses be blinded?

1 reference

12 December 2020

Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma

1 reference

12 December 2020

Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol

1 reference

12 December 2020

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

12 December 2020

A practical guide for calculating indirect costs of disease

1 reference

12 December 2020

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

12 December 2020

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

1 reference

12 December 2020

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

12 December 2020

The St George's Respiratory Questionnaire

1 reference

12 December 2020

10.2165/00019053-199814060-00007

Identifiers

DOI

1 reference

22 May 2018

Dimensions Publication ID

1011206620

0 references

1 reference

22 May 2018